[go: up one dir, main page]

AU4450489A - The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c - Google Patents

The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c

Info

Publication number
AU4450489A
AU4450489A AU44504/89A AU4450489A AU4450489A AU 4450489 A AU4450489 A AU 4450489A AU 44504/89 A AU44504/89 A AU 44504/89A AU 4450489 A AU4450489 A AU 4450489A AU 4450489 A AU4450489 A AU 4450489A
Authority
AU
Australia
Prior art keywords
protein kinase
calmodulin
inhibitor
calcium
ethylenediaminetetraacetic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU44504/89A
Other versions
AU617892B2 (en
Inventor
Ferdinand Hucho
Herbert Kogler
Iris Pribilla
Werner Schiebler
Dominique Tripier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU4450489A publication Critical patent/AU4450489A/en
Application granted granted Critical
Publication of AU617892B2 publication Critical patent/AU617892B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
AU44504/89A 1988-11-10 1989-11-09 The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase II or of protein kinase C Ceased AU617892B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3838068 1988-11-10
DE3838068 1988-11-10

Publications (2)

Publication Number Publication Date
AU4450489A true AU4450489A (en) 1990-05-17
AU617892B2 AU617892B2 (en) 1991-12-05

Family

ID=6366838

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44504/89A Ceased AU617892B2 (en) 1988-11-10 1989-11-09 The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase II or of protein kinase C

Country Status (11)

Country Link
EP (1) EP0368223A3 (en)
JP (1) JPH02180818A (en)
KR (1) KR900007410A (en)
CN (1) CN1042545A (en)
AU (1) AU617892B2 (en)
CA (1) CA2002637A1 (en)
DE (1) DE3937015A1 (en)
DK (1) DK560989A (en)
HU (1) HU204195B (en)
PT (1) PT92281A (en)
ZA (1) ZA898553B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4112103C2 (en) * 1991-02-18 1994-07-14 Matthias Mueller Use of acetic acid to regulate blood sugar levels
AU4205597A (en) * 1996-08-20 1998-03-06 Novartis Ag Methods for prevention of cellular proliferation and restenosis
GB9727224D0 (en) * 1997-12-23 1998-02-25 Nycomed Imaging As Method
DE10138912A1 (en) * 2001-08-08 2003-02-27 Medinnova Ges Med Innovationen Use of active substances for the prophylaxis and / or therapy of viral diseases as well as test system for finding such active substances
HU229104B1 (en) 2007-11-22 2013-07-29 Pharmateka Bt Use of edta and its salts for the prevention and treatment of bacterial intestinal swine diseases caused by brachyspira hyodysenteriae and for enhancement of efficiency of antibiotics in curing such illnesses
EE05628B1 (en) 2010-12-23 2013-02-15 Tallinna Tehnikaülikool Composite polymeric material with mineral fillers
CN111450085A (en) * 2020-05-22 2020-07-28 颜廷良 Broad-spectrum anti-tumor medicine and preparation method and application thereof

Also Published As

Publication number Publication date
ZA898553B (en) 1990-08-29
KR900007410A (en) 1990-06-01
AU617892B2 (en) 1991-12-05
DK560989D0 (en) 1989-11-09
JPH02180818A (en) 1990-07-13
PT92281A (en) 1990-05-31
HU204195B (en) 1991-12-30
HUT51893A (en) 1990-06-28
EP0368223A2 (en) 1990-05-16
CA2002637A1 (en) 1990-05-10
EP0368223A3 (en) 1991-09-25
CN1042545A (en) 1990-05-30
DE3937015A1 (en) 1990-05-17
DK560989A (en) 1990-05-11
HU895861D0 (en) 1990-02-28

Similar Documents

Publication Publication Date Title
PH30794A (en) Inhibition of phosphatidylinositol 3-kinase with worthmannin and analogs thereof.
NO890921D0 (en) PROCEDURE FOR THE PREPARATION OF AMINO ACID DERIVATIVES.
NO882200L (en) PROCEDURE FOR THE PREPARATION OF CALCIUM SULPHATE-ALFA HALIBRATE.
SG53193G (en) Deodorizer for refrigerators of the like
AU3482493A (en) Novel protein tyrosine kinases
AU4680797A (en) Preparation of substituted guanidines
AU3731293A (en) Protein kinase c inhibitor
AU1928688A (en) Tissue factor inhibitor
HU893412D0 (en) Inhibitors of interleucin-1
AU6423590A (en) The treatment of wood chips
AU5102590A (en) Rapid assay for functional human alpha1-proteinase inhibitor
NO881215L (en) PROCEDURE FOR THE PREPARATION OF ALGES WITH IMPROVED BIOLOGICAL EFFECTS.
AU4450489A (en) The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c
FI961378A0 (en) Process for the preparation of N-methyl-3- (1-methyl-4-piperidinyl) -14-indole-5-ethanesulfonamide
ITMI931580A0 (en) PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINS
AU1783092A (en) Inhibitors of protein kinase c function
ITMI931680A0 (en) PROCEDURE FOR THE PREPARATION OF ALKANSULFONAMIDES
GB2251402B (en) Procedure for the manufacture of contour-stable objects
AU1122088A (en) Improvements in the inhibition of lice
AU1368888A (en) Hair growth inhibition using substituted amidines or guanidines
IT8822524A0 (en) PROCEDURE FOR THE PREPARATION OF 6-OXOPENICILLANATES
FI960526A (en) Process for the preparation of cumene hydroperox
AU2608588A (en) Potentiation of antihypertensive effect of ace inhibitors
FI945353A (en) Enzymatic process for the preparation of (S) -6-methoxyl-alpha-methyl-2-naphthaleneacetic acid
AU2632088A (en) Improvements in the inhibition of lice